News Image

ARS Pharmaceuticals Announces neffy® (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies

Provided By GlobeNewswire

Last update: Dec 19, 2024

Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing Type 1 Allergic Reactions

Read more at globenewswire.com

ARS PHARMACEUTICALS INC

NASDAQ:SPRY (2/21/2025, 8:00:02 PM)

After market: 11.21 -0.03 (-0.27%)

11.24

-0.54 (-4.58%)



Find more stocks in the Stock Screener

Follow ChartMill for more